消費者直販型ラボ検査の中東・アフリカ市場2021年ー2031年:産業分析、規模、シェア、成長、動向、予測

◆英語タイトル:Direct-to-Consumer Laboratory Testing Market (Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Chronic Disease Testing, COVID-19 Testing, TSH Testing, and Others; Sample Type: Blood, Saliva, Urine, and Others; and Provider: Hospitals, Clinics, Specialty Labs, and Diagnostic Centers) - Middle East & Africa Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Transparency Market Researchが発行した調査報告書(TMR22JA043)◆商品コード:TMR22JA043
◆発行会社(リサーチ会社):Transparency Market Research
◆発行日:2021年11月16日
◆ページ数:146
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:中東・アフリカ
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,795 ⇒換算¥857,660見積依頼/購入/質問フォーム
Site Licence(同一拠点共有可能)USD8,795 ⇒換算¥1,301,660見積依頼/購入/質問フォーム
Enterprisewide(複数拠点内共有可)USD11,795 ⇒換算¥1,745,660見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社の本調査レポートは、中東・アフリカの消費者直販型ラボ検査市場を調査・分析し、序論、仮定/調査手法、エグゼクティブサマリー、市場概要、キーインサイト、サンプル別分析、検査別分析、提供別分析、競争状況などを掲載しています。

Middle East & Africa Direct-to-Consumer Laboratory Testing Market – Scope of Report
TMR’s report on the direct-to-consumer laboratory testing market in Middle East & Africa studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the revenue of the direct-to-consumer laboratory testing market in MEA for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the direct-to-consumer laboratory testing market in MEA for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the direct-to-consumer laboratory testing market in MEA.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomena in the direct-to-consumer laboratory testing market in MEA.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the direct-to-consumer laboratory testing market in MEA. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the direct-to-consumer laboratory testing market in MEA. The next section of the direct-to-consumer laboratory testing market report highlights the USPs such as key industrial events (licensing partnership/merger & acquisition), disease epidemiology by region/ country/sub-region, COVID-19 pandemic impact on industry (value chain and short/mid/long-term impact), and key success factors of top players operating in the direct-to-consumer laboratory testing market in MEA.

The report also delves into the competition landscape of the direct-to-consumer laboratory testing market in MEA. Key players operating in the direct-to-consumer laboratory testing market in MEA have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, strategic overview, and SWOT are some of the attributes of players in the direct-to-consumer laboratory testing market in MEA profiled in this report.

Key Questions Answered in Middle East & Africa Direct-to-Consumer Laboratory Testing Market Report

What are the major drivers, restraints, and opportunities in the market?
What are the revenue share projections of key segments of the direct-to-consumer laboratory testing market in MEA during the forecast period?
Which segment is likely to lead the direct-to-consumer laboratory testing market in MEA in terms of revenue by 2031?
How technological developments are widening the scope for the direct-to-consumer laboratory testing market in MEA?
What is the market position of different companies operating in the direct-to-consumer laboratory testing market in in MEA?
Middle East & Africa Direct-to-Consumer Laboratory Testing Market – Research Objectives and Research Approach

The comprehensive report on the direct-to-consumer laboratory testing market in MEA begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind the study and healthcare compliances laid down by accredited agencies in the purview of research in the direct-to-consumer laboratory testing market in MEA. It is followed by market introduction, market dynamics, and an overview of the direct-to-consumer laboratory testing market in MEA, which includes TMR analysis of market drivers, restraints, and opportunities affecting the growth of the direct-to-consumer laboratory testing market in MEA. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the direct-to-consumer laboratory testing market in MEA.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the direct-to-consumer laboratory testing market in MEA in terms of test type, sample type, provider, and country/sub-region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the direct-to-consumer laboratory testing market.

❖ レポートの目次 ❖

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: MEA Direct-to-Consumer Laboratory Testing Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industrial Events (licensing partnerships/mergers & acquisitions)
5.2. Disease Prevalence & Incidence Rate
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Sample Type, 2017–2031
6.3.1. Blood
6.3.2. Urine
6.3.3. Saliva
6.3.4. Others
6.4. Market Attractiveness Analysis, by Sample Type
7. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Test Type, 2017–2031
7.3.1. Genetic Testing
7.3.1.1. Nutrigenetics Test
7.3.1.1.1. Weight Control
7.3.1.1.2. Lactose Intolerance
7.3.1.1.3. Others
7.3.1.2. Celiac Disease Test
7.3.1.3. Sports & Physical Activity Testing
7.3.1.4. Men’s Health Tests
7.3.1.5. Women’s Health Tests
7.3.1.6. Pregnancy & Prenatal Screening Test
7.3.1.7. General Health Testing
7.3.1.8. Others
7.3.2. Disease Risk Assessment Testing
7.3.2.1. Sexual Health Tests
7.3.2.1.1. HIV
7.3.2.1.2. Chlamydia
7.3.2.1.3. Others
7.3.2.2. Cancer Predisposition Tests
7.3.2.3. Others
7.3.3. CBC
7.3.4. Chronic Disease Testing
7.3.4.1. Diabetes Testing
7.3.4.2. Hypertension
7.3.4.3. Others
7.3.5. COVID-19 Testing
7.3.6. TSH Testing
7.3.7. Others
7.4. Market Attractiveness Analysis, by Test Type
8. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Provider
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Provider, 2017–2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Specialty Labs
8.3.4. Diagnostic Centers
8.4. Market Attractiveness Analysis, by Provider
9. GCC Countries Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Sample Type, 2017–2031
9.2.1. Blood
9.2.2. Urine
9.2.3. Saliva
9.2.4. Others
9.3. Market Value Forecast, by Test Type, 2017–2031
9.3.1. Genetic Testing
9.3.1.1. Nutrigenetics Test
9.3.1.1.1. Weight Control
9.3.1.1.2. Lactose Intolerance
9.3.1.1.3. Others
9.3.1.2. Celiac Disease Test
9.3.1.3. Sports & Physical Activity Testing
9.3.1.4. Men’s Health Tests
9.3.1.5. Women’s Health Tests
9.3.1.6. Pregnancy & Prenatal Screening Test
9.3.1.7. General Health Testing
9.3.1.8. Others
9.3.2. Disease Risk Assessment Testing
9.3.2.1. Sexual Health Tests
9.3.2.1.1. HIV
9.3.2.1.2. Chlamydia
9.3.2.1.3. Others
9.3.2.2. Cancer Predisposition Tests
9.3.2.3. Others
9.3.3. CBC
9.3.4. Chronic Disease Testing
9.3.4.1. Diabetes Testing
9.3.4.2. Hypertension
9.3.4.3. Others
9.3.5. COVID-19 Testing
9.3.6. TSH Testing
9.3.7. Others
9.4. Market Value Forecast, by Provider, 2017–2031
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Specialty Labs
9.4.4. Diagnostic Centers
10. South Africa Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Sample Type, 2017–2031
10.2.1. Blood
10.2.2. Urine
10.2.3. Saliva
10.2.4. Others
10.3. Market Value Forecast, by Test Type, 2017–2031
10.3.1. Genetic Testing
10.3.1.1. Nutrigenetics Test
10.3.1.1.1. Weight Control
10.3.1.1.2. Lactose Intolerance
10.3.1.1.3. Others
10.3.1.2. Celiac Disease Test
10.3.1.3. Sports & Physical Activity Testing
10.3.1.4. Men’s Health Tests
10.3.1.5. Women’s Health Tests
10.3.1.6. Pregnancy & Prenatal Screening Test
10.3.1.7. General Health Testing
10.3.1.8. Others
10.3.2. Disease Risk Assessment Testing
10.3.2.1. Sexual Health Tests
10.3.2.1.1. HIV
10.3.2.1.2. Chlamydia
10.3.2.1.3. Others
10.3.2.2. Cancer Predisposition Tests
10.3.2.3. Others
10.3.3. CBC
10.3.4. Chronic Disease Testing
10.3.4.1. Diabetes Testing
10.3.4.2. Hypertension
10.3.4.3. Others
10.3.5. COVID-110 Testing
10.3.6. TSH Testing
10.3.7. Others
10.4. Market Value Forecast, by Provider, 2017–2031
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Specialty Labs
10.4.4. Diagnostic Centers
11. Rest of MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Sample Type, 2017–2031
11.2.1. Blood
11.2.2. Urine
11.2.3. Saliva
11.2.4. Others
11.3. Market Value Forecast, by Test Type, 2017–2031
11.3.1. Genetic Testing
11.3.1.1. Nutrigenetics Test
11.3.1.1.1. Weight Control
11.3.1.1.2. Lactose Intolerance
11.3.1.1.3. Others
11.3.1.2. Celiac Disease Test
11.3.1.3. Sports & Physical Activity Testing
11.3.1.4. Men’s Health Tests
11.3.1.5. Women’s Health Tests
11.3.1.6. Pregnancy & Prenatal Screening Test
11.3.1.7. General Health Testing
11.3.1.8. Others
11.3.2. Disease Risk Assessment Testing
11.3.2.1. Sexual Health Tests
11.3.2.1.1. HIV
11.3.2.1.2. Chlamydia
11.3.2.1.3. Others
11.3.2.2. Cancer Predisposition Tests
11.3.2.3. Others
11.3.3. CBC
11.3.4. Chronic Disease Testing
11.3.4.1. Diabetes Testing
11.3.4.2. Hypertension
11.3.4.3. Others
11.3.5. COVID-19 Testing
11.3.6. TSH Testing
11.3.7. Others
11.4. Market Value Forecast, by Provider, 2017–2031
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Specialty Labs
11.4.4. Diagnostic Centers
12. Competition Landscape
12.1. Market Player – Competition Matrix (by tier and size of companies)
12.2. Company Profiles
12.2.1. 23andMe, Inc.
12.2.1.1. Company Description
12.2.1.2. Business Overview
12.2.1.3. Strategic Overview
12.2.1.4. SWOT Analysis
12.2.2. Ancestry
12.2.2.1. Company Description
12.2.2.2. Business Overview
12.2.2.3. SWOT Analysis
12.2.3. CircleDNA
12.2.3.1. Company Description
12.2.3.2. Business Overview
12.2.3.3. SWOT Analysis
12.2.4. Eurofins Scientific
12.2.4.1. Company Description
12.2.4.2. Business Overview
12.2.4.3. Financial Overview
12.2.4.4. SWOT Analysis
12.2.5. Family Tree DNA (Gene by Gene)
12.2.5.1. Company Description
12.2.5.2. Business Overview
12.2.5.3. SWOT Analysis
12.2.6. Laboratory Corporation of America Holdings
12.2.6.1. Company Description
12.2.6.2. Business Overview
12.2.6.3. Financial Overview
12.2.6.4. Strategic Overview
12.2.6.5. SWOT Analysis
12.2.7. Living DNA Ltd.
12.2.7.1. Company Description
12.2.7.2. Business Overview
12.2.7.3. SWOT Analysis
12.2.8. Medichecks.com Ltd.
12.2.8.1. Company Description
12.2.8.2. Business Overview
12.2.8.3. SWOT Analysis
12.2.9. MyHeritage Ltd.
12.2.9.1. Company Description
12.2.9.2. Business Overview
12.2.9.3. SWOT Analysis
12.2.10. MyMedLab, Inc.
12.2.10.1. Company Description
12.2.10.2. Business Overview
12.2.10.3. SWOT Analysis
12.2.11. Quest Diagnostics Incorporated
12.2.11.1. Company Description
12.2.11.2. Business Overview
12.2.11.3. Financial Overview
12.2.11.4. Strategic Overview
12.2.11.5. SWOT Analysis

List of Tables

Table 01: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 02: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 03: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 04: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 05: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 06: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 07: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 08: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 09: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 10: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 11: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 12: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 13: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 14: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 15: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 16: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 17: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 18: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 19: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 20: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 21: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 22: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 23: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 24: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 25: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 26: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 27: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 28: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 29: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 30: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 31: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 32: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

List of Figures

Figure 01: MEA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 02: MEA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 03: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Blood, 2017–2031

Figure 04: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

Figure 05: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

Figure 06: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 07: MEA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 08: MEA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 09: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Genetic Testing, 2017–2031

Figure 10: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Disease Risk Assessment Testing, 2017–2031

Figure 11: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by CBC, 2017–2031

Figure 12: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Chronic Disease Testing, 2017–2031

Figure 13: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by COVID-19 Testing, 2017–2031

Figure 14: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by TSH Testing, 2017–2031

Figure 15: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 16: MEA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 17: MEA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 18: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Hospitals, 2017–2031

Figure 19: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Clinics, 2017–2031

Figure 20: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Specialty Labs, 2017–2031

Figure 21: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Diagnostic Centers, 2017–2031

Figure 22: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 23: GCC Countries Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 24: GCC Countries Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 25: GCC Countries Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 26: GCC Countries Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 27: GCC Countries Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 28: GCC Countries Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 29: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 30: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 31: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 32: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 33: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 34: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 35: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 消費者直販型ラボ検査の中東・アフリカ市場2021年ー2031年:産業分析、規模、シェア、成長、動向、予測(Direct-to-Consumer Laboratory Testing Market (Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Chronic Disease Testing, COVID-19 Testing, TSH Testing, and Others; Sample Type: Blood, Saliva, Urine, and Others; and Provider: Hospitals, Clinics, Specialty Labs, and Diagnostic Centers) - Middle East & Africa Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆